L. P

A Clinical Study of Biomarkers to Predict the Efficacy of Cancer Immunotherapy with Subcutaneous Low-Dose II-2 or with Immune Checkpoint Inhibitors

M. G., Lissoni P, Brivio F, 2019, Oncogen.

Expression of orphan GPR 56 correlates with tumor progression in human epithelial ovarian cancer

Z. Huang, Z. Liu, H. B, 2017 .

A Review on Cancer Progression - Related Pineal Endocrine Deficiency:Possible Mechanisms and Clinical Implications

P. Lissoni, F. Rovelli, L. P, 2016 .